Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1990
DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targetsD F Hayes, D S Silberstein, S W Rodrique, et al.
Biochemistry|December 27, 1977
Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structureT M Rothgeb, B N Jones, D F Hayes, et al.
Journal of Comparative Pathology|August 29, 2016
Epithelial Cell Adhesion Molecule Expression in Canine TumoursD H Thamm, D F Hayes, T Meuten, et al.
Blood|February 1, 1988
Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigenD F Hayes, H Sekine, D Marcus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancerC L Vogel, J Schoenfelder, I Shemano, et al.
Cancer Research|July 15, 1988
Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancerC Tondini, D F Hayes, R Gelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992
Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptorL Damstrup, J Andersen, D W Kufe, et al.
Cancer Research|February 15, 1990
Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrowC Tondini, S A Pap, D F Hayes, et al.
The Journal of Clinical Investigation|May 1, 1985
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patientsD F Hayes, H Sekine, T Ohno, et al.
Cancer Research|May 1, 1992
Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigenL Perey, D F Hayes, P Maimonis, et al.
Pageof 15